Tyrophostins

N/A

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameTyrophostins
Drug Alias NameDegrasynsCP-2005WP-1130
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitorsAnticancer protein kinase inhibitorsApoptosis stimulants +[6] 
TargetsTyrosine-protein kinase JAK2Myc proto-oncogene proteinBcr-Abl tyrosine kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer CenterCallisto Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A